GREENWAY ET AL.: 'Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo.' J CLIN ENDOCRINOL METAB vol. 94, no. 12, 2009, pages 4898 - 4906, XP055100385 (B1)

GREENWAY FRANK L. ET AL: "Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 94, no. 12, December 2009 (2009-12), pages 4898-4906, XP055100385, US ISSN: 0021-972X, DOI: 10.1210/jc.2009-1350 (B1)

HAUSENLOY D J: "Contrave(TM): Novel treatment for obesity", CLINICAL LIPIDOLOGY 2009 FUTURE MEDICINE LTD. GBR, vol. 4, no. 3, June 2009 (2009-06), pages 279-285, XP009176559, ISSN: 1746-0875 (B1)

JOHNSON FRANKLIN ET AL: "Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules", ADVANCES IN THERAPY, vol. 27, no. 11, 14 October 2010 (2010-10-14), pages 846-858, XP055104393, ISSN: 0741-238X, DOI: 10.1007/s12325-010-0074-x (B1)

MIDHA K K ET AL: "Exposure measures applied to the bioequivalence of two sustained release formulations of bupropion.", INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS MAY 2005, vol. 43, no. 5, May 2005 (2005-05), pages 244-254, XP009176514, ISSN: 0946-1965 (B1)

US-A1- 2008 058 407 (B1)

WILCOXA ET AL.: 'An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.' ADDICTIVE BEHAVIORS vol. 35, March 2010, pages 229 - 234, 230, XP026809862 (B1)

US-A1- 2008 113 026 (B1)

US-A1- 2010 166 889 (B1)

US-B2- 7 375 111 (B1)

US-B2- 7 682 633 (B1)

WADDEN ET AL.: 'Weight Loss with Naltexone Sr/Bupropion Sr Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial.' OBESITY vol. 19, no. 1, 17 June 2010, pages 110 - 120, XP055100388 (B1)

US-A1- 2008 110 792 (B1)